Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| VIVUS INC | 15,000 | reported | 20 Feb 2020 | tx 39+450,000−113,841 |
| QLT INC/BC | 9,600 | reported | 22 Dec 2016 | tx 1+9,600 |
| Aegerion Pharmaceuticals, Inc. | 0 | reported | 29 Nov 2016 | tx 2+31,182−31,182 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2020 | GRANT_AWARD | VIVUS INC | 15,000 | 0.00 USD | deriv |
| 26 Oct 2018 | GRANT_AWARD | VIVUS INC | 15,000 | 0.00 USD | deriv |
| 27 Oct 2017 | OTHER | VIVUS INC | 3,762 | 0.70 USD | |
| 27 Oct 2017 | EXERCISE | VIVUS INC | 12,500 | — | |
| 27 Oct 2017 | EXERCISE | VIVUS INC | 12,500 | 0.00 USD | deriv |
| 27 Oct 2017 | GRANT_AWARD | VIVUS INC | 150,000 | 0.00 USD | deriv |
| 08 Aug 2017 | OTHER | VIVUS INC | 3,762 | 1.01 USD | |
| 08 Aug 2017 | EXERCISE | VIVUS INC | 12,500 | — | |
| 08 Aug 2017 | EXERCISE | VIVUS INC | 12,500 | 0.00 USD | deriv |
| 15 Jun 2017 | OTHER | VIVUS INC | 3,762 | 1.17 USD | |
| 08 May 2017 | EXERCISE | VIVUS INC | 12,500 | — | |
| 08 May 2017 | EXERCISE | VIVUS INC | 12,500 | 0.00 USD | deriv |
| 08 Feb 2017 | OTHER | VIVUS INC | 3,762 | 1.08 USD | |
| 08 Feb 2017 | EXERCISE | VIVUS INC | 12,500 | — | |
| 08 Feb 2017 | EXERCISE | VIVUS INC | 12,500 | 0.00 USD | deriv |
| 13 Jan 2017 | GRANT_AWARD | VIVUS INC | 50,000 | 0.00 USD | deriv |
| 22 Dec 2016 | GRANT_AWARD | QLT INC/BC | 9,600 | 0.00 USD | deriv |
| 29 Nov 2016 | OTHER | Aegerion Pharmaceuticals, Inc. | 31,182 | — | deriv |
| 31 Oct 2016 | OTHER | VIVUS INC | 940 | 1.05 USD | |
| 31 Oct 2016 | EXERCISE | VIVUS INC | 3,125 | — | |
| 31 Oct 2016 | EXERCISE | VIVUS INC | 3,125 | 0.00 USD | deriv |
| 30 Sept 2016 | EXERCISE | VIVUS INC | 3,125 | — | |
| 30 Sept 2016 | OTHER | VIVUS INC | 940 | 1.14 USD | |
| 30 Sept 2016 | EXERCISE | VIVUS INC | 3,125 | 0.00 USD | deriv |
| 31 Aug 2016 | EXERCISE | VIVUS INC | 3,125 | — |